Japan Pranlukast Market Size & Outlook, 2026-2034


Japan Pranlukast Market Insights

  • As per Reed Intelligence insights, the Japan Pranlukast Market stood at USD 16.77 Billion in 2025 and is anticipated to grow to USD 37.65 Billion by 2034.
  • The Japan market is expected to advance at a CAGR of 9.44% from 2026 through 2034.
  • In 2025, Tablets accounted for the highest share of the Formulation Type market size.
  • During the forecast period, Capsules is set to register the highest growth, making it the most lucrative Formulation Type segment.

Other Key Findings


  • As of 2025, Japan held 2.26% of the global Pranlukast Market size.
  • By 2034, United States is anticipated to capture the largest share of the global Pranlukast Market.
  • In Asia Pacific, China is expected to lead the regional Pranlukast Market size by 2034.
  • Taiwan will remain the fastest-growing market in Asia Pacific, reaching USD 15.13 Billion by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 16.77 Billion
Market Size In 2034 USD 37.65 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 9.44% (2026-2034)
Segmnetation Covered
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends